Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference56 articles.
1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011
2. Estimation of cancer incidence and mortality attributable to smoking in China;JB Wang;Cancer Causes Control,2010
3. Cancer statistics, 2010;A Jemal;CA Cancer J Clin,2010
4. Screening for lung cancer, an ongoing debate;PE Postmus;Ann Oncol,2008
5. Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?;K Konopa;Ann Oncol,2010
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Localized Cas12a-based cascade amplification for sensitive and robust detection of APE1;Talanta;2024-12
2. Label-free colorimetric detection platform based on catalytic hairpin self-assembly and G-quadruplex/hemin DNAzyme for comprehensive biomarker profiling;Talanta;2024-05
3. The DNA-repair protein APE1 participates with hnRNPA2B1 to motif-enriched and prognostic miRNA secretion;Oncogene;2024-04-25
4. The Effect of Family Characteristics on the Functioning of a Child with an Autistic Spectrum Disorder in Bedouin Society in Israel;Journal of Autism and Developmental Disorders;2024-02-15
5. The DNA-repair protein APE1 participates with hnRNPA2B1 to motif-enriched and prognostic miRNA secretion;2024-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3